Controversies in Thrombosis and Hemostasis Congress (CiTH) 2014 Berlin

  • Conference Call
  • It is our plea­sure to invite you to par­tic­i­pate in the Con­tro­ver­sies in Throm­bo­sis and Hemo­sta­sis Con­gress (CiTH) which will be held in Berlin, Ger­many on Octo­ber 30-Novem­ber 2, 2014 at the Mar­itime proArte Hotel.

    CiTH is a ‘con­cept con­gress’ deal­ing mainly with con­tro­ver­sial issues in the for­mat of debates and dis­cus­sions allow­ing ample time for speaker-​participant inter­ac­tion. Con­gresses are becom­ing more and more spe­cial­ized and monothe­matic, allow­ing lim­ited time to fully dis­cuss clin­i­cal mean­ing and the line between Evi­dence Based Med­i­cine (EBM) and work­ing the­o­ries or ideas that are pre­ma­ture to imple­ment into prac­tice. CiTH addresses this need by facil­i­tat­ing effec­tive debate on unre­solved clin­i­cal and ther­a­peu­tic dilem­mas, sup­ported by expert opin­ions result­ing in agree­ment on timely issues.

    The abil­ity to dis­cuss con­tro­ver­sial top­ics with empha­sis on clin­i­cal solu­tions in cases where no agreed-​upon answers exist pro­vides clin­i­cians with an insight and a take-​home mes­sage that ame­lio­rates treat­ment in the most dif­fi­cult situations.

    What is CiTH?

    • Aca­d­e­mic gath­er­ing for physi­cians and scientists
    • Devoted to clin­i­cal controversies
    • Focused on debates and discussions
    • Crit­i­cal dis­cus­sions on con­tro­ver­sial issues
    • Ample time for speaker-​participant interaction
    • Lead­ing forum for opin­ion lead­ers, clin­i­cians and industry
    • Reaches best clin­i­cal rec­om­men­da­tions & solu­tions for ther­a­peu­tic dilemmas

    Con­gress Topics

    Throm­botic dis­or­ders & antithrombotics

    • Throm­bophilia screen: Always /​Never
    • Role of throm­bophilia in ges­ta­tion com­pli­ca­tion: Major /​Minor
    • Heparins in the next 10 years: Extin­guish /​Pre­vail
    • War­farin in the next 10 years: Extin­guish /​Pre­vail
    • Direct throm­bin inhibitors and fac­tor Xa inhibitors: Which one to choose for VTE treat­ment and prevention?
    • Direct throm­bin inhibitors and fac­tor Xa inhibitors: Which one to choose for CAF?
    • Should we mon­i­tor anti platelet ther­apy: Always /​Never
    • New antiplatelet agents: Ulti­mate solu­tion /​Lim­ited application
    • Phar­ma­coge­nomics: The ulti­mate tool /​Use­less and expensive
    • The role of catheter guided throm­bol­y­sis in DVT: Rou­tine prac­tice /​Not yet sup­ported by evidence
    • Extended VTE pro­phy­laxis in med­ically ill patients: Yes /​No
    • Pri­mary pre­ven­tion of coro­nary heart dis­ease by ASA: Yes /​No

    Bleed­ing disorders

    • Plasma derived vs. recom­bi­nant fac­tor VIII con­cen­trate: Which one to choose?
    • The role of throm­bopoi­et­ics in ITP: 1st line /​3rd line /​replac­ing splenec­tomy? Con­trol of bleed­ing asso­ci­ated with new oral anti­co­ag­u­lants: Not an issue /​Yet to be developed
    • Replace­ment ther­apy before surgery of fac­tor XI & fac­tor VII defi­cient patient: No /​When?


    • Should infants with peri­na­tal throm­bo­sis be screened for throm­bophilia and treated by antocoagulants?
    • Is there a role for pri­mary anto­co­ag­u­lants pro­l­phy­laxis in chil­dren with ALL?
    • Pro­phy­laxis for chil­dren with hemo­philia should start early or after joint bleed? Is low dose reg­i­men prefer­able to stan­dard dose?
    • Should we screen chil­dren for coag­u­lopathies prior to surgery?

    CME Accreditation

    Serono Sym­posia Inter­na­tional Foun­da­tion will sub­mit the main con­gress pro­gram of the Con­tro­ver­sies in Throm­bo­sis and Hemo­sta­sis Con­gress (CiTH), Berlin, Ger­many, Octo­ber 30-​November 2, 2014, for accred­i­ta­tion by the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EACCME).

    For the Ital­ian participants

    This pro­gram of the Con­tro­ver­sies in Throm­bo­sis and Hemo­sta­sis Con­gress (CiTH), Berlin, Ger­many, Octo­ber 30-​November 2, 2014, will be sub­mit­ted for CME accred­i­ta­tion from the Ital­ian Min­istry of Health.

    The CME accred­i­ta­tion is valid for the main con­gress pro­gram only and does not cover the company-​sponsored symposia.

    ISO 9001 Certification

    Serono Sym­posia Inter­na­tional Foun­da­tion has received the ISO 9001 Cer­ti­fi­ca­tion of Qual­ity Man­age­ment Sys­tems. This Qual­ity cer­ti­fi­ca­tion requires all par­tic­i­pants to fill in a sci­en­tific ques­tion­naire and to eval­u­ate the over­all qual­ity of the event. Ques­tion­naires will be dis­trib­uted onsite dur­ing the congress.

    CME for USA participants

    UEMS/​EACCME CME credit recog­ni­tion – The Amer­i­can Med­ical Asso­ci­a­tion (AMA) has an agree­ment of mutual recog­ni­tion of con­tin­u­ing med­ical edu­ca­tion (CME) credit with the Euro­pean Union of Med­ical Spe­cial­ties (UEMS). Under the terms of this agree­ment, the AMA will con­vert CME credit cer­ti­fied by the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EAC­CME), the accred­it­ing arm of the UEMS, to AMA PRA Cat­e­gory 1 Credit™. Physi­cians (MDs, DOs or equiv­a­lent inter­na­tional degree) may have their EAC­CME credit con­verted to AMA PRA Cat­e­gory 1 Credit™ by apply­ing to the AMA.

    starting: ending: 02.11.2014 Location: , Category:


    Conference START 02.11.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Maritim proArte Hotel, Friedrichstraße 151 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.